Award

01KT2304B

Funder: European Commission

Funded outputs count: 14

Funder award ID: 01KT2304B

OpenAlex ID: G5373097964

Stemness overcomes IFNγ-induced antitumour exhaustion in human macrophages

2026 · Jessica Nitsche, Clara Jana-Lui Busch, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Patient-derived resources for decoding and targeting brain metastases ecosystems

2026 · Manuel Valiente, Lal Era Aydoğan, et al. · EMBO Molecular Medicine

Tumor–infiltrating CD8+Ki-67+ and CD8+LAG-3+ T cells are associated with improved patient survival in retroperitoneal dedifferentiated liposarcomas and leiomyosarcomas

2026 · Iva Benesova, Antonia Stammberger, et al. · Experimental and Molecular Pathology

Intratumoral regulatory T cells are associated with treatment response to neoadjuvant chemotherapy and prognosis in gastroesophageal adenocarcinoma

2025 · Franziska Baenke, Antonia Stammberger, et al. · OncoImmunology · 1

Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancer

2025 · David Digomann, Charlotte Reiche, et al. · iScience · 2

Multi-compartment immune cell profiling highlights the prognostic relevance of CD127+ CD8+ T cells for patients with high-grade serous ovarian cancer

2025 · Rebecca Rothe, Antje Tunger, et al. · Frontiers in Immunology · 2

2176P Serum levels of galectin-9 predict the survival of patients with gastric and gastroesophageal junction adenocarcinoma

2025 · D. Digomann, C. Reiche, et al. · Annals of Oncology

2178TiP Fecal microbiota capsules from healthy donors to improve treatment response in patients with locally advanced, resectable gastric or gastro-esophageal junction adenocarcinoma: A randomized, placebo-controlled phase II study (CAPGO)

2025 · T. van den Ende, S. Siegerink, et al. · Annals of Oncology · 1

Tertiary Lymphoid Structures Are Associated with Progression-Free Survival of Peripheral Neuroblastic Tumor Patients

2025 · Rebecca Rothe, Therés Golle, et al. · Cancers · 2

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors

2025 · Lino Möhrmann, Lysann Rostock, et al. · Med · 16

RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activation

2025 · Eugenia Crespo, Liliana R. Loureiro, et al. · npj Precision Oncology · 8

TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells

2024 · Neibla Priego, Ana de Pablos-Aragoneses, et al. · Cancer Discovery · 53

Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients

2024 · Johanna Kirchner, Ioana Plesca, et al. · Frontiers in Immunology · 14

Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche

2024 · Susann Winter, Katharina S. Götze, et al. · Leukemia · 41